Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up

Chinese Journal of Cancer

Volumn 28, Issue 9, 2009, Pages 994-999

  Hu, Ying Ying ^a   Sun, Xin Ru ^a   Lin, Xiao Ping ^a   Liang, Pei Yan ^a   Zhang, Xu ^a   Fan, Wei ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Cervix cancer; PET CT; Squamous cell carcinoma antigen; Tumor recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG SQUAMOUS CELL CARCINOMA; METASTASIS; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; UTERINE CERVIX CANCER;

EID: 77649296603     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10097     Document Type: Article

References (10)

1. Ferrandina G, Macchia G, Legge F, et al. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome [J]. Oncology, 2008, 74 (1-2): 42-49.
2. Ohno T, Nakayama Y, Nakamota S, et al. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix [J]. Cancer, 2003, 97: 3114-3120.
3. Forni F, Ferrandina G, Deodato F, et al. Squamous cell carcinoma in follow-up cervical cancer treated with radiotherapy: evaluation of cost-effectiveness [J]. Int J Radiat Oncal Biol Phys, 2007, 69(4): 1145-1149.
4. Hirakawa M, Nagai Y, Inamine M, et al. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy [J]. Gynecol Oncol, 2008, 108(1): 126-129.
5. Micke O, Prott FJ, Schäfer U, et al. The impact of squamous cell carcinoma(SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer [J]. Anticancer Res, 2000, 20 (6D): 5113-5115.
6. Ma SK, Wu LY, Sun YC, et al. Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix [J]. Zhonghua Fu Chan Ke Za Zhi, 2008, 43 (1): 13-17. [in Chinese]
7. Hong JH, Tsai CS, Chang TC, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy [J]. Int J Radiat Oncol Biol Phys, 2004, 60(1): 249-257.
8. Kidd EA, Siegel BA, Dehdashti F, et al. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival [J]. Cancer, 2007, 110(8): 1738-1744.
9. Kato H, Takita J, Miyazaki T, et al. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma [J]. Anticancer Res, 2003, 23 (4): 3263-3272.
10. Chang TC, Law KS, Hong JH, et al. Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study [J]. Cancer, 2004, 101(1): 164-171.